Epidemiological Characteristics of Myelodysplastic Syndrome in France
Author Information
Author(s): M Maynadie, C Verret, P Moskovtchenko, F Mugneret, T Petrella, D Caillot, PM Carlil
Primary Institution: Registre des Hemopathies Malignes de C6te d'Or, France
Hypothesis
What are the incidence and prognosis of myelodysplastic syndromes (MDS) in a well-defined French population?
Conclusion
The study found a crude incidence rate of 3.2 per 100,000 per year for MDS, with a significant male predominance and a 5-year survival rate of 23%.
Supporting Evidence
- The crude incidence rate of MDS was found to be 3.2 per 100,000 per year.
- RAEB was the most frequent subtype of MDS observed.
- The overall 5-year transformation rate of MDS was 31%.
- The prognosis of RAEB in transformation was worse than other subtypes.
- Significant male predominance was noted in all age groups.
Takeaway
This study looked at how often a blood disorder called myelodysplastic syndrome happens in a specific area of France and found that older people are more likely to get it.
Methodology
Data was collected from a population-based registry of haematopoietic malignancies in Cote d'Or, France, covering cases diagnosed between 1980 and 1990.
Potential Biases
There may be selection bias due to the reliance on hospital-based statistics and the criteria for diagnosing MDS.
Limitations
The study may not fully represent the true incidence of MDS due to potential underdiagnosis in asymptomatic patients.
Participant Demographics
The population studied consisted of 493,931 inhabitants, with a male predominance in MDS cases.
Statistical Information
P-Value
p<0.01
Confidence Interval
31% ± 4% for transformation rate; 23% ± 3% for survival rate.
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website